Citation Impact
1 from Science/Nature 50 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
Works of Mathilde Kaper being referenced
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1
2020 Standout
Preliminary findings from part 1 of COMBI-i: A phase III study of anti–PD-1 antibody PDR001 combined with dabrafenib (D) and trametinib (T) in previously untreated patients (pts) with advanced BRAF V600-mutant melanoma.
2018
Author Peers
| Author | Molecular Biology | Urology | Oncology | PRM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Mathilde Kaper | 259 | 195 | 234 | 233 | 16 | 851 | |
| Glen Blake | 281 | 4 | 158 | 8 | 5 | 633 | |
| H Solomon | 26 | 148 | 5 | 5 | 5 | 455 | |
| Salvatore Dinardo | 6 | 6 | 35 | 630 | |||
| Christopher Burlak | 117 | 2 | 32 | 12 | 20 | 436 | |
| Alice S. Y. Chow | 26 | 602 |
All Works
Loading papers...